The Worldwide Antacids Industry is Expected to Reach $6.56 Billion by 2026 at a CAGR of 3.6% from 2021 -

DUBLIN--()--The "Global Antacids Market (2021-2026), by Drug Class, Formulation, Distribution Channel, Geography and the Impact of COVID-19 with Ansoff Analysis" report has been added to's offering.

Antacids are usually over the counter (OTC) medications used in neutralizing stomach acid. The market has seen wide availability of antacids in variety of forms. Manufacturers in the antacids market are approaching different drug formulation techniques to support flavoured, chewable tablets to capture the market.

The Global Antacids Market is estimated to be USD 5.5 Bn in 2021 and is expected to reach USD 6.56 Bn by 2026 growing at a CAGR of 3.6%.

Rising incidence of acidic refluxes like GERD, unhealthy lifestyle etc. have driven the growth of the market. However, the alternative market for antacids hinders the growth of this market.

Segments Covered

The Global Antacid market is further segmented on the basis of drug class, formulation, distribution channel and geography.

Global Antacids Market, By Drug Class

  • Introduction
  • Proton Pump Inhibitor
  • H2 Antagonist
  • Acid Neutralizers

Global Antacids Market, By Formulation

  • Introduction
  • Tablet
  • Liquid
  • Powder

Global Antacids Market, By Distribution Channel

  • Introduction
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Antacids Market, By Geography

  • Introduction
  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Antacids Market.
  • The report includes in-depth qualitative analysis, verifiable data from authentic sources and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys and observation of renowned personnel in the industry.
  • The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
  • The report also contains the competitive analysis using Competitive Quadrant, the analyst's proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Market Dynamics


  • Increasing Prevalence of Gastro Esophageal Reflux Diseases (GERD)
  • Growing Geriatric Population
  • Increasing Prevalence Of Heartburn
  • Unhealthy lifestyle


  • Growing number of alternatives in the market for antacids


  • Increasing awareness about GERD


  • Rise of E-commerce has augmented the demand for antacids
  • Melt in mouth antacid

Companies Mentioned

  • Wellspring Pharm
  • Private Lable
  • Johnson & Johnson
  • Novartis Consumer Health
  • Boehringer Ingelheim Pharm
  • Glaxosmithkline
  • Procter & Gamble
  • First Aid Only
  • Pfizer
  • Bayer AG
  • Dr Reddy's Laboratories
  • Reckitt Benckiser Group plc
  • Sanofi
  • Sun Pharmaceuticals
  • Takeda Pharmaceutical Company Limited
  • Abbott

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900